3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial (Q44436492)
Jump to navigation
Jump to search
scientific article published on January 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial |
scientific article published on January 1, 2003 |
Statements
1 reference
3-month formulation of goserelin acetate ('Zoladex' 10.8-mg depot) in advanced prostate cancer: results from an Italian, open, multicenter trial (English)
1 reference
3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial (English)
1 reference
1 reference
D. Fontana
M. Mari
A. Martinelli
C. Boccafoschi
C. Magno
M. Turriziani
S. S. Maymone
S. Cosciani Cunico
A. Zanollo
G. Montagna
M. Frongia
1 January 2003
1 reference
1 reference
70
1 reference
4
1 reference
316-320
1 reference
Identifiers
1 reference
1 reference